Dr. Bsisu

As we age, we experience a decline in our metabolism and metabolic function. Researchers at Mayo Clinic have identified the enzyme, called CD38, that is responsible for the decrease in nicotinamide adenine dinucleotide (NAD) during aging, a process that is associated with age-related metabolic decline. Results demonstrated an increase in the presence of CD38 with aging in both mice and humans. read the article:  http://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-link-specific-enzyme-to-process-of-metabolic-dysfunction-in-aging/?linkId=25536304

Future brain therapies for Parkinson's possible with stem cell bioengineering innovation Scientists at Rutgers and Stanford universities have created a new technology that could someday help treat Parkinson's disease and other devastating brain-related conditions that affect millions of people. 😍 😍  We encourage our colleagues to read more about this subject, so they can come up with new ideas for new researches 😍 😍 Read the Article: http://www.eurekalert.org/pub_releases/2016-03/ru-fbt031616.php#.VuqOJvT9M84.reddit